Position
Chief Medical Officer
Company
PAQ Therapeutics
BurlingtonBiotechnologyHealth CareTherapeuticsDescription
PAQ Therapeutics has announced the appointment of Andrew Krivoshik, MD, PhD, as Chief Medical Officer. Dr. Krivoshik will lead clinical strategies as the company advances its lead asset, PT0253, and aims to develop innovative KRAS degraders.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- CytoDyn Appoints Robert E. Hoffman as Chief Financial Officer (May 6, 2025)
- Priothera Appoints Jens Hasskarl as Chief Medical Officer (May 6, 2025)
- BioNTech Appoints Ramón Zapata as Chief Financial Officer (May 5, 2025)
- Cellarity Appoints Ted Myles as Chief Executive Officer (May 12, 2025)
- Aera Therapeutics Appoints Paul Conrad as Chief Business and Financial Officer (May 12, 2025)
- Orca Bio Appoints Nate Fernhoff as Chief Executive Officer (May 13, 2025)
Who to call at PAQ Therapeutics, and when
A new leader at PAQ Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day PAQ Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PAQ Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PAQ Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PAQ Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
PAQ Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.